Neulasta 6 MG/0.6 ML syringe 0.6ML
Ended Awarded
- Contract number
- SPE2DB25FJJ34
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,077
Award facts
- Contract value 100% obligated
- $28,076.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,076.54 delivery order to AmerisourceBergen Drug Corp for Neulasta 6 mg/0.6 ml syringes on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price contract represents a non-competitive set-aside delivery order utilizing the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and maintains a $999,999,999 prime IDC with DLA through December 2026 that enables supply of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order for Neulasta, a specialty pharmaceutical used in oncology support, exemplifies AmerisourceBergen's role as a major vendor within the Defense Health Agency supply chain. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements through competitive processes and established contract vehicles. As a child order under the DLA Troop Support Medical framework, this award reflects the ongoing pharmaceutical procurement needs of military healthcare systems and the company's position as a preferred vendor for critical medical commodities delivery across the department of defense enterprise.
Quick answers
Who was awarded contract SPE2DB25FJJ34?
SPE2DB25FJJ34 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FJJ34 worth?
The government has obligated $28,077 on SPE2DB25FJJ34.
Is contract SPE2DB25FJJ34 an order under another contract?
Yes. SPE2DB25FJJ34 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJJ34 competed?
The extent of competition for SPE2DB25FJJ34 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award